BioNTech gets $145 mln funding for African vaccine plants

COVID-19 vaccine maker BioNTech (22UAy.DE) has secured up to $145 million in funding from a global coalition against infectious diseases to help build a production network in Africa for shots based on cutting-edge messenger-RNA (mRNA) technology.